Moderna Inc MRNA

Healthcare Biotechnology

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.

NDAQ:MRNA - Post by User

Moderna Inc > Moderna can hit 245$ monday!!

<< Previous

Bullboard Posts

Next >>

Comment by 7Twiggyon Dec 21, 2020 4:48pm

142 Views

Post# 32154997

RE:Moderna can hit 245$ monday!!

Let's be realistic. Think this thing has excellent long term prospects. Should move up slowly.
Money Managers playing games. Don't think we will see any big jumps., but like Shopify, most of the conservative analyst's got it wrong. Put some in most of my registered accounts for a hold.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals